ACHC vs HCA vs NHC Stock Comparison

Acadia Healthcare Company, HCA Healthcare and National Healthcare Prices as of Nov 13, 2026 Peers: Industry group
HCA HCA Healthcare, Inc.
$499.31 +6.1% 1M +5.5% 1Y
Market cap
$108.84B
P/E
16.1x
Revenue (TTM)
$78.70B
Div. yield
–
Hospitals Healthcare
7 wins
NHC National Healthcare Corp
$208.19 -11.3% 1M +64.4% 1Y
Market cap
$3.20B
P/E
27.9x
Revenue (TTM)
$1.58B
Div. yield
0.01%
Home Health and Senior Care Healthcare
2 wins

Head to Head

11 decided of 12

HCA Healthcare leads on 7 of the 12 questions below (HCA Healthcare 7, Acadia Healthcare Company 2, National Healthcare 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionACHCHCANHCLeader
Larger companyMarket capitalisation $3.51B $108.84B $3.20B HCA
Cheaper on earningsLower P/E, profitable companies only -3.1x 16.1x 27.9x HCA
Cheaper on forward earningsLower price / next fiscal year consensus EPS 21.1x 16.2x — HCA
Faster revenue growthRevenue growth, trailing twelve months +4.5% +5.8% +5.6% HCA
More profitableNet margin, trailing twelve months -33.1% 8.6% 7.2% HCA
Better return on capitalReturn on invested capital -24.6% 21.8% 8.6% HCA
Less leveragedLower net debt / EBITDA -2.5x 3.1x 1.4x ACHC
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.01% –
Better 1-year returnPrice return, last 12 months +135.0% +5.5% +64.4% ACHC
Better 5-year returnAnnualised price return, 5 years -10.2%/yr +15.3%/yr +23.3%/yr NHC
Less volatileAnnualised volatility, 1 year 64.1% 32.7% 34.6% HCA
Higher overall scoreMean of the five percentile scores vs peers 25/100 58/100 61/100 NHC

Percentile Scorecard

ACHCHCANHC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisACHCHCANHC
Valuation 41 #59 of 99 78 #23 of 99 50 #50 of 99
Growth 2 #87 of 89 24 #68 of 89 52 #43 of 89
Profitability 24 #70 of 92 96 #5 of 92 75 #24 of 92
Financial Health 33 #69 of 103 15 #88 of 103 69 #33 of 103
Shareholder Returns – 81 #13 of 63 60 #26 of 63
Overall 25 58 61
  • ACHC ranked among 103 companies in Healthcare Providers
  • HCA ranked among 103 companies in Healthcare Providers
  • NHC ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodACHCHCANHCSPY
1 month +19.3%+6.1%-11.3% -2.0%
3 months +22.5%+23.4%-6.5% -2.8%
6 months +46.4%+18.0%+7.5% +2.0%
Year to date +166.2%+7.0%+51.9% +10.6%
1 year +135.0%+5.5%+64.4% +12.2%
3 years -48.6%+110.2%+177.8% +68.1%
3 years, per year -19.9%+28.1%+40.6% +18.9%
5 years -41.6%+103.6%+184.3% +61.4%
5 years, per year -10.2%+15.3%+23.3% +10.1%
10 years -2.6%+617.6%+208.3% +248.5%
10 years, per year -0.3%+21.8%+11.9% +13.3%

Risk

MeasureACHCHCANHCSPY
Volatility, 1Y 64.1%32.7%34.6% 13.6%
Downside volatility, 1Y 63.4%30.3%32.0% 13.9%
Beta vs S&P 500, 1Y 0.700.280.20 1.00
Return / volatility, 1Y 2.100.171.86 0.90
Max drawdown, 5Y -86.9%-39.7%-34.4% -25.4%
From 52-week high -2.6%-8.4%-15.8% -3.2%
52-week high $38.80$545.13$247.31 $779.14
52-week low $11.68$361.32$124.93 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleACHCHCANHC
P/E now vs peer median -3.0xmedian 22.4x 15.8xmedian 22.4x 28.4xmedian 22.4x
P/S now vs peer median 1.0xmedian 1.3x 1.3xmedian 1.3x 2.1xmedian 1.3x
EV/EBITDA now vs peer median -6.4xmedian 14.2x 9.7xmedian 14.2x 17.4xmedian 14.2x
P/FCF now vs peer median -143.9xmedian 19.0x 17.6xmedian 19.0x -8.4xmedian 19.0x
P/B now vs peer median 1.7xmedian 2.6x -13.0xmedian 2.6x 2.9xmedian 2.6x
PEG now vs peer median 0.01median 0.84 1.09median 0.84 0.81median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsACHCHCANHC
Revenue $3.41B $78.70B $1.58B
Gross profit $3.29B $67.30B –
Operating income -$1.08B $12.19B $154.94M
Net income -$1.12B $7.80B $116.02M
Free cash flow -$23.86M $5.97B -$388.63M
EPS (diluted) $-12.29 $31.20 $7.18
Cash & equivalents $163.31M $908.00M $66.80M
Total debt $2.35B $50.49B $502.06M
Shares (diluted) 91.75M 217.21M 15.96M
Enterprise value $2.89B $103.20B $2.25B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricACHCHCANHC
P/E -3.0x 15.8x 28.4x
P/FCF -143.9x 17.6x -8.4x
P/Operating cash flow 14.6x 9.4x 14.7x
P/S 1.0x 1.3x 2.1x
P/B 1.7x -13.0x 2.9x
P/Tangible book 1.8x -13.0x 2.9x
EV/EBITDA -6.4x 9.7x 17.4x
EV/EBIT -5.2x 12.7x 22.9x
EV/Revenue 1.6x 2.0x 2.2x
EV/FCF -235.7x 25.9x -9.1x
EV/Operating cash flow 23.9x 13.8x 16.0x
PEG (3Y EPS CAGR) 0.01 1.09 0.81

Growth

14 metrics
MetricACHCHCANHC
Revenue growth (1Y) 4.5% 5.8% 5.6%
Revenue CAGR (3Y) 6.0% 7.6% 12.8%
Gross profit growth (1Y) 4.4% 6.3% –
Gross profit CAGR (3Y) 6.1% 8.0% –
Operating income growth (1Y) -863.4% 6.0% 24.8%
Operating income CAGR (3Y) -262.5% 4.9% 49.8%
Net income growth (1Y) -1,044% 6.8% 12.2%
Net income CAGR (3Y) -350.5% 4.3% 39.3%
EPS growth (1Y) -1,137% 16.1% 11.1%
EPS CAGR (3Y) -294.4% 14.6% 35.0%
Operating cash flow growth (1Y) -29.8% -13.0% 22.5%
Operating cash flow CAGR (3Y) -20.0% 6.4% 31.5%
Free cash flow growth (1Y) 93.1% -26.2% -364.6%
Free cash flow CAGR (3Y) -31.5% 10.9% -94.5%

Profitability

14 metrics
MetricACHCHCANHC
Gross margin 96.4% 85.5% –
EBITDA margin -25.6% 20.3% 12.9%
Operating margin -31.7% 15.5% 9.8%
Pretax margin -31.7% 12.5% 9.5%
Net margin -33.1% 8.6% 7.2%
FCF margin -0.7% 7.6% -24.5%
Operating cash flow margin 6.9% 14.2% 14.0%
Return on equity -56.1% – 10.3%
Return on assets -20.2% 12.3% 6.4%
Return on invested capital -24.6% 21.8% 8.6%
Return on capital employed -21.6% 28.0% 10.2%
Asset turnover 0.6x 1.2x 0.9x
Cash conversion (OCF / net income) -0.2x 1.4x 1.9x
Stock comp / revenue 1.0% 0.5% 0.4%

Financial Health

11 metrics
MetricACHCHCANHC
Debt / assets 42.3% 79.6% 24.3%
Debt / equity 1.2x -6.3x 0.4x
Net debt / EBITDA -2.5x 3.1x 1.4x
Debt / FCF -98.6x 8.5x -1.3x
Liabilities / assets 63.6% 112.7% 45.3%
Equity / assets 36.4% -12.7% 54.7%
Interest coverage – 5.2x 19.2x
Current ratio 1.6x 0.8x 1.5x
Quick ratio 1.2x 0.7x 1.2x
Cash ratio 0.3x 0.1x 0.8x
Altman Z-score 0.45 2.52 3.78

Shareholder Returns

7 metrics
MetricACHCHCANHC
Dividend yield – 0.6% 1.3%
Net buyback yield – 8.7% 0.1%
Shareholder yield – 9.3% 1.4%
Payout ratio (earnings) – – 34.8%
Payout ratio (FCF) – – -10.4%
Dividend growth (1Y) – – 5.7%
Dividend CAGR (3Y) – – 4.6%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusACHCHCANHC
Forward P/E 21.1xFY2026 16.2xFY2026 –
EPS, next fiscal year $1.79FY2026 $30.83FY2026 –
EPS growth, next FY -10.5%FY2026 +9.3%FY2026 –
EPS growth, the year after +18.4% +6.2% –
Revenue, next fiscal year $3.55BFY2026 $73.66BFY2026 –
Revenue growth, next FY +7.2%FY2026 -2.6%FY2026 –
Revenue growth, the year after +7.2% +18.0% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersACHCHCANHC
Held by institutions 100.0% 59.5% 65.3%
Institutions holding 314 1,339 250
Change in shares held, QoQ +3.7% +0.3% -0.6%
Institutions buying 165 569 136
Institutions selling 98 565 72
Buyers to sellers 1.68 1.01 1.89

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ACHCHCANHC
ACHC 1.00 0.21 0.25
HCA 0.21 1.00 0.28
NHC 0.25 0.28 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ACHC, HCA and NHC?

HCA Healthcare (HCA) is the largest by market capitalisation: Acadia Healthcare Company (ACHC) $3.51B, HCA Healthcare (HCA) $108.84B, National Healthcare (NHC) $3.20B.

Which stock is cheaper, ACHC, HCA and NHC?

HCA Healthcare (HCA) trades on the lowest price-to-earnings ratio (Acadia Healthcare Company (ACHC) -3.1x, HCA Healthcare (HCA) 16.1x, National Healthcare (NHC) 27.9x). On next year's consensus earnings, HCA Healthcare (HCA) is cheapest (Acadia Healthcare Company (ACHC) 21.1x, HCA Healthcare (HCA) 16.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

HCA Healthcare (HCA) grew revenue fastest over the trailing twelve months: Acadia Healthcare Company (ACHC) +4.5%, HCA Healthcare (HCA) +5.8%, National Healthcare (NHC) +5.6%.

Which company is more profitable?

HCA Healthcare (HCA) has the highest net margin (Acadia Healthcare Company (ACHC) -33.1%, HCA Healthcare (HCA) 8.6%, National Healthcare (NHC) 7.2%). On return on invested capital, HCA Healthcare (HCA) leads (Acadia Healthcare Company (ACHC) -24.6%, HCA Healthcare (HCA) 21.8%, National Healthcare (NHC) 8.6%).

Which stock has performed better?

Over the past year Acadia Healthcare Company (ACHC) returned the most: Acadia Healthcare Company (ACHC) +135.0%, HCA Healthcare (HCA) +5.5%, National Healthcare (NHC) +64.4%. Over five years, National Healthcare (NHC) compounded fastest (Acadia Healthcare Company (ACHC) -10.2%/yr, HCA Healthcare (HCA) +15.3%/yr, National Healthcare (NHC) +23.3%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Acadia Healthcare Company (ACHC) 0.00%, HCA Healthcare (HCA) 0.00%, National Healthcare (NHC) 0.01%. Acadia Healthcare Company (ACHC) and HCA Healthcare (HCA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, HCA Healthcare (HCA) has been the steadiest (Acadia Healthcare Company (ACHC) 64.1%, HCA Healthcare (HCA) 32.7%, National Healthcare (NHC) 34.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ACHC, HCA and NHC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, HCA Healthcare (HCA) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.